4543 Stock Overview
Engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 4543 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Terumo Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3,062.00 |
| 52 Week High | JP¥3,182.00 |
| 52 Week Low | JP¥2,134.00 |
| Beta | 0.41 |
| 1 Month Change | 0.36% |
| 3 Month Change | 12.28% |
| 1 Year Change | 32.50% |
| 3 Year Change | 26.01% |
| 5 Year Change | 62.87% |
| Change since IPO | 2,478.53% |
Recent News & Updates
Calculating The Intrinsic Value Of Terumo Corporation (TSE:4543)
Dec 26
Terumo Corporation (TSE:4543) Not Flying Under The Radar
Dec 11Terumo Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 11Recent updates
Calculating The Intrinsic Value Of Terumo Corporation (TSE:4543)
Dec 26Terumo Corporation (TSE:4543) Not Flying Under The Radar
Dec 11Terumo Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 11Returns At Terumo (TSE:4543) Appear To Be Weighed Down
Nov 08Estimating The Fair Value Of Terumo Corporation (TSE:4543)
Sep 16Terumo Corporation Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next
Aug 11Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)
Jul 21Terumo (TSE:4543) Has A Pretty Healthy Balance Sheet
Jul 05Return Trends At Terumo (TSE:4543) Aren't Appealing
Jun 20Calculating The Fair Value Of Terumo Corporation (TSE:4543)
May 12Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)
Apr 12Terumo (TSE:4543) Has Announced A Dividend Of ¥22.00
Mar 27Is Terumo (TSE:4543) Using Too Much Debt?
Feb 29Shareholder Returns
| 4543 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 0.1% | 2.0% | 3.6% |
| 1Y | 32.5% | 14.8% | 16.3% |
Return vs Industry: 4543 exceeded the JP Medical Equipment industry which returned 14.8% over the past year.
Return vs Market: 4543 exceeded the JP Market which returned 16.3% over the past year.
Price Volatility
| 4543 volatility | |
|---|---|
| 4543 Average Weekly Movement | 2.8% |
| Medical Equipment Industry Average Movement | 3.4% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.2% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4543 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4543's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | n/a | Hikaru Samejima | www.terumo.com |
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts.
Terumo Corporation Fundamentals Summary
| 4543 fundamental statistics | |
|---|---|
| Market cap | JP¥4.53t |
| Earnings (TTM) | JP¥119.49b |
| Revenue (TTM) | JP¥986.67b |
37.9x
P/E Ratio4.6x
P/S RatioIs 4543 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4543 income statement (TTM) | |
|---|---|
| Revenue | JP¥986.67b |
| Cost of Revenue | JP¥456.87b |
| Gross Profit | JP¥529.80b |
| Other Expenses | JP¥410.32b |
| Earnings | JP¥119.49b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | 80.70 |
| Gross Margin | 53.70% |
| Net Profit Margin | 12.11% |
| Debt/Equity Ratio | 13.3% |
How did 4543 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield30%
Payout RatioDoes 4543 pay a reliable dividends?
See 4543 dividend history and benchmarks| Terumo dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 27 2025 |
| Days until Ex dividend | 87 days |
| Days until Dividend pay date | 178 days |
Does 4543 pay a reliable dividends?
See 4543 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 18:15 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Terumo Corporation is covered by 33 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Liu | Aletheia Analyst Network Limited |
| Masahiro Nakanomyo | Barclays |
| Craig Nelson | BNP Paribas Securities (Asia) |